Rectal Cancer Global Clinical Trials Review, H2, 2013

GlobalData
November 30, 2013
131 Pages - SKU: GBDT5167364
EpiCast Report: Allergic Conjunctivitis - Epidemiology Forecast to 2023
10/7/2014 | published by: GlobalData
EpiCast Report: Allergic Conjunctivitis - Epidemiology Forecast to 2023 Summary Allergic conjunctivitis is an inflammation of the eye resulting from an allergic reaction to allergy causing substances (external antigens) like pollen, dander, mold, or other substances. In  |  read more...
USD 3,995
Malignant Melanoma: KOL Insight
10/17/2014 | published by: FirstWord
Introduction Malignant Melanoma: PD-1 inhibitors revolutionise treatment is a comprehensive report with insights from 12 leading US and European KOLs offering their latest views on current and late-stage pipeline products, why and  |  read more...
USD 6,495
Legionella Control (UK) - Industry Report
10/7/2014 | published by: Plimsoll Publishing Ltd.
Plimsoll’s UK Legionella Control (UK) analysis is the most definitive and accurate study of the UK Legionella Control (UK) sector in 2014. The report is split into two sections and uses both a written and graphical  |  read more...
USD 560
Biotechnology (Pharmaceuticals) (Global) - Industry Report
10/7/2014 | published by: Plimsoll Publishing Ltd.
Plimsoll’s Biotechnology (UK) analysis is the most definitive and accurate study of the Biotechnology (UK) sector in 2014. The report is split into two sections and uses both a written and graphical analysis – analysing the  |  read more...
USD 1,520
Clinical Trails Market in India - 2014
10/13/2014 | published by: Feedback Business Consulting Services Pvt. Ltd.
Clinical Trails Market in India - 2014 This report provides an insight into the Clinical Trails current market scenario, structure and practices in India. In depth market scenario includes; Market estimate of Clinical Trails in India for FY14 Share  |  read more...
USD 4,000
KOL Insight: Multiple Sclerosis
10/6/2014 | published by: FirstWord
Introduction Recent launches of oral therapies have brought clinical advantages and clear patient benefits and are set to transform the treatment of Multiple Sclerosis (MS). The question is, which products will  |  read more...
USD 6,495
Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H2, 2014
10/7/2014 | published by: GlobalData
Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H2, 2014 provides data on the Chemotherapy Induced Peripheral Neuropathy clinical trial scenario.  |  read more...
USD 2,500
Global Proton Therapy Market 2014-2018
10/15/2014 | published by: TechNavio - Infiniti Research Ltd.
Global Proton Therapy Market 2014-2018 About Proton Therapy Proton therapy is a type of particle therapy which is used to treat cancer patients by means of proton beams irradiation. The main advantage of proton therapy is that  |  read more...
USD 2,500
EpiCast Report: Dyslipidemia - Epidemiology Forecast to 2023
10/15/2014 | published by: GlobalData
Wind Power in Australia, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles Summary Wind Power in Australia, Market Outlook to 2025, Update 2014 - Capacity,  |  read more...
USD 3,995
Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014
9/22/2014 | published by: Global Markets Direct
Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014’, provides an overview of the Refractory Chronic Lymphocytic Leukemia (CLL)’s therapeutic pipeline. This report  |  read more...
USD 2,000
 

SELECT A LICENSE

    Online Download  USD 2,500  
    Site License  USD 5,000  
    Global Site License  USD 7,500  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!